Predictive Factors for Patients Undergoing ASD Device Occlusion Who "Crossover" to Surgery.
Mulukutla, Venkatachalam; Qureshi, Athar M; Pignatelli, Ricardo; Ing, Frank F.
; 39(3): 445-449, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29138879
Percutaneous Ventricular Septal Defect Closure in Patients Under 1 Year of Age.
Mid-Term Outcomes after Percutaneous Closure of the Secundum Atrial Septal Defect with the Figulla-Occlutech Device.
Transcatheter Closure of Atrial Septal Defects: Comparable Experience and Outcomes Between Developing and Developed Countries.
Transcatheter Closure of Patent Ductus Arteriosus in Children with the Occlutech Duct Occluder.
Corrected balloon occlusive diameter to determine device size during percutaneous atrial septal defect closure.
Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.
Percutaneous removal of unraveled HELEX® septal occluder 4 months post deployment.
Transcatheter closure of atrial septal defect in a patient with absent inferior caval vein connection: a novel technique using a steerable guide catheter.
Techniques for transcatheter retrieval of the occlutech ASD device United Kingdom-European multicenter report.
The Effect on Somatic Growth of Surgical and Catheter Treatment of Secundum Atrial Septal Defects.